| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8792291 | Journal of American Association for Pediatric Ophthalmology and Strabismus | 2017 | 21 Pages |
Abstract
This study found travoprost to be noninferior to timolol in lowering IOP in patients with pediatric glaucoma or ocular hypertension. Travoprost was well-tolerated, and no treatment-related systemic adverse events were reported.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
El Roy MD, Theresa PhD, Subha PhD, Nancy MS, Craig OD, Yasmin MD, Leyla Ali MD, FRCS, Robert MD,